MedTrace Logo

Improved Language Acquisition With Levodopa

NCT00103805 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-05-21

No results posted yet for this study

Summary

The purpose of this study is to determine whether the non-daily administration of levodopa is effective in boosting semantic language acquisition in healthy subjects.

Conditions

  • Healthy

Interventions

DRUG

levodopa

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Caterina Breitenstein, PhD · Dept. of Neurology, University of Muenster, Germany

  • Stefan Knecht, MD · Dept. of Neurology, University of Muenster, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2005-08-31
Completion
2005-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00103805 on ClinicalTrials.gov